Sharekhan's research report on Max Financial Services
Axis Bank has announced that it will buy the balance ~7% stake in Max Life from Max Financial at fair market value using discounted cash flows (DCF) instead of valuation as per Rule 11UA of the Income Tax Rules, 1962. The revision in valuation has been done consequent to the guidance received from IRDAI (Insurance Regulator). With this announcement, uncertainty over the Axis Bank Bancassurance tie-up with Max also goes away. The bank has not disclosed the revised valuation; however, we expect the revised valuation for the balance 7% stake should be atleast ~ Rs. 22 billion (i.e Rs.166/- per share of Max Life because as per the annual report 2022, Max Financial acquired 0.74% stake of Max Life from Axis Bank at Rs.166 per share during March 2021), which would be higher by Rs. 18 billion compared to the earlier transfer price.
Outlook
We believe now the key catalyst would be the reverse merger of Max Financials with Max Life Insurance along with the listing of Max Life Insurance. Valuations are inexpensive, factoring some uncertainty about the event. We maintain our Buy rating on the stock with an unchanged PT of Rs. 1,020.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
